MaRS Innovation Forms Strategic Partnership with Pfizer
Toronto-based MaRS Innovation, a commercialization agent for Ontario's discovery pipeline from academic institutions, has formed a strategic partnership with pharmaceuticals company Pfizer Inc. intended to advance early-stage technologies related to human health in therapeutics and diagnostics. MaRS and Pfizer will jointly identify opportunities emerging from scientific research discoveries within MaRS Innovation's 16 member institutions, including the University of Toronto.
22 April 2013•3 mins read
